Literature DB >> 35403158

Rectal Phenotype of Perianal Paget Disease: Rare Concomitant Phenomena.

Yuki Tateishi1, Yuichi Yamada1, Takeo Yamamoto1, Taisuke Sasaki1, Shinichiro Kawatoko1, Jun Kawata1, Yutaka Yamada1, Masafumi Nakamura2, Masaki Mori3, Yoshinao Oda1.   

Abstract

Aim: Classically, 'Paget disease' refers to a distinct histological pattern in breast carcinoma. Here, we review the clinicopathological features of anorectal adenocarcinoma with 'pagetoid' spread. Materials and
Methods: Histological and immunohistochemical records for 11 cases of anorectal adenocarcinoma with pagetoid spread among 958 Japanese patients with primary rectal/anal carcinoma were reviewed.
Results: Grossly, nine of 11 cases had areas of invasive carcinoma: Tubular adenocarcinoma in eight and neuroendocrine carcinoma in one. Pagetoid components were positive for cytokeratin 7 in eight cases, cytokeratin 20 and caudal type homeobox 2 in all 11 cases, and p63 in one case, but were negative for estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), gross cystic disease fluid protein-15, and GATA binding protein 3.
Conclusion: The prevalence of perianal Paget disease in this series was 1.1%, with two cases of genuine perianal Paget disease with a rectal phenotype without invasive carcinoma. The rectal phenotype of perianal Paget disease may not be associated with HER2 overexpression. Copyright 2021, International Institute of Anticancer Research.

Entities:  

Keywords:  HER2; Perianal Paget disease; rectal adenocarcinoma

Year:  2021        PMID: 35403158      PMCID: PMC8962862          DOI: 10.21873/cdp.10051

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  15 in total

1.  Anal canal neuroendocrine carcinoma with Pagetoid extension.

Authors:  Limei Guo; Naoto Kuroda; Eriko Miyazaki; Yulan Jin; Makoto Toi; Tadashi Hamauzu; Makoto Hiroi; Takeshi Inoue; Atsushi Inoue; Hideaki Enzan
Journal:  Pathol Int       Date:  2004-08       Impact factor: 2.534

Review 2.  The spontaneous regression of cancer. A review of cases from 1900 to 1987.

Authors:  G B Challis; H J Stam
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

3.  The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease.

Authors:  T Ohnishi; S Watanabe
Journal:  Br J Dermatol       Date:  2000-02       Impact factor: 9.302

Review 4.  Anorectal mucinous adenocarcinoma associated with latent perianal Paget's disease.

Authors:  M Sasaki; T Terada; Y Nakanuma; N Kono; Y Kasahara; K Watanabe
Journal:  Am J Gastroenterol       Date:  1990-02       Impact factor: 10.864

5.  Rectal carcinoma associated with pagetoid phenomenon.

Authors:  Ritsuko Haga; Hiroyuki Suzuki
Journal:  Eur J Dermatol       Date:  2003 Jan-Feb       Impact factor: 3.328

6.  The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.

Authors:  John Perrotto; Jared J Abbott; Roger I Ceilley; Iftikhar Ahmed
Journal:  Am J Dermatopathol       Date:  2010-04       Impact factor: 1.533

7.  A comparative study of cytokeratin expression in Paget cells located at various sites.

Authors:  S Watanabe; T Ohnishi; H Takahashi; Y Ishibashi
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

8.  Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma.

Authors:  Joseph M Anderson; Reshma Ariga; Hema Govil; Kenneth J Bloom; Darius Francescatti; Vijaya B Reddy; Victor E Gould; Paolo Gattuso
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-06

9.  Perianal Paget's disease: report of five cases.

Authors:  S Goldman; T Ihre; U Lagerstedt; C Svensson
Journal:  Int J Colorectal Dis       Date:  1992-09       Impact factor: 2.571

10.  Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.

Authors:  R Tanaka; Y Sasajima; H Tsuda; K Namikawa; A Tsutsumida; F Otsuka; N Yamazaki
Journal:  Br J Dermatol       Date:  2013-06       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.